06/03/2026
UTHealth Houston has become the first health center in Texas to offer Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), an FDA-approved treatment for adults with treatment-resistant depression.
Bill Henderson, 75, is the first patient in Texas to receive the innovative therapy. The treatment is offered by a team led by João L. de Quevedo, MD, PhD, director of the Treatment-Resistant Depression Program at the Center for Interventional Psychiatry at McGovern Medical School at UTHealth Houston.
Learn more about this breakthrough and Bill’s story at go.uth.edu/BillSAINT.